Correlation Between Virax Biolabs and Avenue Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Avenue Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Avenue Therapeutics.
Diversification Opportunities for Virax Biolabs and Avenue Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Virax and Avenue is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Avenue Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Avenue Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.45 times more return on investment than Avenue Therapeutics. However, Virax Biolabs is 1.45 times more volatile than Avenue Therapeutics. It trades about -0.1 of its potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.24 per unit of risk. If you would invest 221.00 in Virax Biolabs Group on November 3, 2024 and sell it today you would lose (52.00) from holding Virax Biolabs Group or give up 23.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Avenue Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Avenue Therapeutics |
Virax Biolabs and Avenue Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Avenue Therapeutics
The main advantage of trading using opposite Virax Biolabs and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Virax Biolabs Group | Avenue Therapeutics vs. Palisade Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |